228 related articles for article (PubMed ID: 35338336)
1. Diuretics versus others for long-term clinical outcomes as first-line antihypertensive medications: analysis of national real-world database.
Kim HL; Hwang D; Lee JH; Lee HY; Ihm SH; Kim KI; Shin J; Park S; Kim DH; Sung KC
Hypertens Res; 2022 May; 45(5):758-768. PubMed ID: 35338336
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis.
Suchard MA; Schuemie MJ; Krumholz HM; You SC; Chen R; Pratt N; Reich CG; Duke J; Madigan D; Hripcsak G; Ryan PB
Lancet; 2019 Nov; 394(10211):1816-1826. PubMed ID: 31668726
[TBL] [Abstract][Full Text] [Related]
3. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Calcium Channel Blockers Versus Other Classes of Antihypertensive Medication in the Treatment of Hypertensive Patients With Previous Stroke and/or Coronary Artery Disease: A Systematic Review and Meta-Analysis.
Jeffers BW; Robbins J; Bhambri R
Am J Ther; 2017; 24(1):e68-e80. PubMed ID: 26588586
[TBL] [Abstract][Full Text] [Related]
5. Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker.
Tsai MS; Tang CH; Lin CY; Chuang PY; Chen NC; Huang CH; Chang WT; Wang TD; Yu PH; Chen WJ
Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):535-543. PubMed ID: 29218625
[TBL] [Abstract][Full Text] [Related]
6. Comparative risk of new-onset diabetes mellitus for antihypertensive drugs in elderly: A Bayesian network meta-analysis.
Zhang J; Tong A; Dai Y; Niu J; Yu F; Xu F
J Clin Hypertens (Greenwich); 2019 Aug; 21(8):1082-1090. PubMed ID: 31241860
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up.
Jeong HS; Lim HS; Park HJ; Lee WS; Choi JO; Lee HS; Jo SH; Hong SJ
Sci Rep; 2021 Jan; 11(1):1783. PubMed ID: 33469103
[TBL] [Abstract][Full Text] [Related]
8. Renin-Angiotensin System Inhibitors vs Other Antihypertensives in Hypertensive Blacks: A Meta-Analysis.
Palla M; Ando T; Androulakis E; Telila T; Briasoulis A
J Clin Hypertens (Greenwich); 2017 Apr; 19(4):344-350. PubMed ID: 27378313
[TBL] [Abstract][Full Text] [Related]
9. Use of Antihypertensive Drugs and Ischemic Stroke Severity - Is There a Role for Angiotensin-II?
Hwong WY; Bots ML; Selvarajah S; Abdul Aziz Z; Sidek NN; Spiering W; Kappelle LJ; Vaartjes I
PLoS One; 2016; 11(11):e0166524. PubMed ID: 27846309
[TBL] [Abstract][Full Text] [Related]
10. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
11. Beta-blockers for hypertension.
Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Opie LH
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002003. PubMed ID: 28107561
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.
Levi-Marpillat N; Macquin-Mavier I; Tropeano AI; Parati G; Maison P
Hypertens Res; 2014 Jun; 37(6):585-90. PubMed ID: 24671016
[TBL] [Abstract][Full Text] [Related]
13. Beta-blockers for hypertension.
Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
[TBL] [Abstract][Full Text] [Related]
14. Comparing Outcomes Between Thiazide Diuretics and Other First-line Antihypertensive Drugs in Long-term Nursing Home Residents.
Boockvar KS; Song W; Lee S; Intrator O
Clin Ther; 2020 Apr; 42(4):583-591. PubMed ID: 32229030
[TBL] [Abstract][Full Text] [Related]
15. The effects of calcium channel blockers in the prevention of stroke in adults with hypertension: a meta-analysis of data from 273,543 participants in 31 randomized controlled trials.
Chen GJ; Yang MS
PLoS One; 2013; 8(3):e57854. PubMed ID: 23483932
[TBL] [Abstract][Full Text] [Related]
16. Long-term comparative effectiveness of antihypertensive monotherapies in primary prevention of cardiovascular events: a population-based retrospective inception cohort study in the Netherlands.
Li X; Bijlsma MJ; Bos JHJ; Schuiling-Veninga CCM; Hak E
BMJ Open; 2023 Aug; 13(8):e068721. PubMed ID: 37558444
[TBL] [Abstract][Full Text] [Related]
17. Lack of association of antihypertensive drugs with the risk and severity of COVID-19: A meta-analysis.
Ren L; Yu S; Xu W; Overton JL; Chiamvimonvat N; Thai PN
J Cardiol; 2021 May; 77(5):482-491. PubMed ID: 33168337
[TBL] [Abstract][Full Text] [Related]
18. The benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers combined with calcium channel blockers on metabolic, renal, and cardiovascular outcomes in hypertensive patients: a meta-analysis.
Pongpanich P; Pitakpaiboonkul P; Takkavatakarn K; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P
Int Urol Nephrol; 2018 Dec; 50(12):2261-2278. PubMed ID: 30324578
[TBL] [Abstract][Full Text] [Related]
19. Analysis of prescription status of antihypertensive drugs in Chinese patients with hypertension based on real-world study.
Yang R; Tang J; Kuang M; Liu H
Ann Med; 2023 Dec; 55(1):276-284. PubMed ID: 36594446
[TBL] [Abstract][Full Text] [Related]
20. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]